(Q38168128)

English

Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).

scientific article published on 03 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297502%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297502%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297502%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Frédéric Sebag

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297502%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Michael Brauckhoff

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297502%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

0 references

publication date

3 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297502%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Langenbeck's Archives of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297502%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

399

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297502%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297502%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

185-197

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297502%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

https://scigraph.springernature.com/pub.10.1007/s00423-013-1139-5

0 references

German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Medullary thyroid cancer: management guidelines of the American Thyroid Association

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Serum calcitonin estimation in medullary thyroid cancer: basal or stimulated levels?

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers - the role of Ct serum level

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

The prevalence of occult medullary thyroid carcinoma at autopsy

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

C-cell hyperplasia and medullary thyroid microcarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC).

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Sporadic hypercalcitoninemia: clinical and therapeutic consequences

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

C-Cell Hyperplasia Preceding Medullary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Genotype-phenotype correlation in multiple endocrine neoplasia type 2

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Management of medullary thyroid carcinoma and MEN2 syndromes in childhood.

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A.

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Early Malignant Progression of Hereditary Medullary Thyroid Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Hereditary medullary thyroid cancer: age-appropriate thyroidectomy improves disease-free survival

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Measurement of calcitonin by immunoassay analyzers.

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Reference intervals for serum calcitonin in men, women, and children

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Biomarker-based risk stratification for previously untreated medullary thyroid cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Medullary thyroid microcarcinoma recommendations for treatment - a single-center experience.

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Influence of lymph node metastases on survival in pediatric medullary thyroid cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Determinants of life expectancy in medullary thyroid cancer: age does not matter.

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Management of hyperparathyroidism (PHP) in MEN2 syndromes in Europe

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience.

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery

1 reference

https://api.crossref.org/works/10.1007%2FS00423-013-1139-5

21 January 2018

Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunostains for collagen type IV discriminate between C-cell hyperplasia and microscopic medullary carcinoma in multiple endocrine neoplasia, type 2a

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morbidity following thyroid surgery: does surgeon volume matter?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normal range of calcitonin in children measured by a chemiluminescent two-site immunometric assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of C cells in the normal and diseased thyroid gland.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extrathyroidal manifestations of multiple endocrine neoplasia type 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation stu

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Thyroid Association guidelines for management of medullary thyroid cancer: an adult endocrinology perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medullary carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for reporting C cell pathology of the thyroid.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A perspective from pediatric endocrinology on the hereditary medullary thyroid carcinoma syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C cell hyperplasia/neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic thyroidectomy in RET carriers at risk for hereditary medullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What the surgeon of tomorrow needs to know about evidence-based surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00423-013-1139-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297502%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24297502%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38168128&oldid=1510639617"